Nelly Rwamba Mugo
From Wikipedia, the free encyclopedia
Nelly Rwamba Mugo is a Kenyan physician and clinical researcher. She is Senior Principal Clinical Research Scientist at the Kenya Medical Research Institute (KEMRI) and Research Associate Professor in the Department of Global Health at the University of Washington.[1]
Mugo studied medicine at the University of Nairobi, where she earned a Bachelor of Medicine and Bachelor of Surgery (MBChB) and later a Master of Medicine in Obstetrics and Gynaecology (MMed).[2] She obtained a Master of Public Health (MPH) in epidemiology from the University of Washington in 2000.[3]
Career
Mugo is a clinician and researcher with a focus on HIV prevention, sexually transmitted infections, and cervical cancer. She leads the Partners in Health Research and Development (PHRD) clinical research team in Thika, Kenya.[1]
She was an investigator in the Partners PrEP Study, which demonstrated the effectiveness of antiretroviral medication as pre-exposure prophylaxis (PrEP) among serodiscordant couples. She also serves as protocol lead of the KENya Single-dose HPV Vaccine-Efficacy (KEN SHE) Study, which evaluates the use of a single-dose HPV vaccine.[3]
Mugo has contributed to national and international health policy development, including guideline work with the Kenya Ministry of Health and the World Health Organization.[1]
Awards and recognition
- Elected Fellow of the African Academy of Sciences (2019).[1]
- Recipient of the Gita Ramjee Prize for HIV prevention research, awarded by the International AIDS Society and The Aurum Institute (2021).[4]